We are live on ! Find out more
LICN icon

Lichen China

4 hedge funds and large institutions have $57.5K invested in Lichen China in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more funds holding

Funds holding: 34 (+1)

0% more ownership

Funds ownership: 0%0% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

21% less capital invested

Capital invested by funds: $72.7K → $57.5K (-$15.2K)

Holders
4
Holders Change
+1
Holders Change %
+33.33%
% of All Funds
0.06%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
1
Increased
1
Reduced
1
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$24.6K
2
UBS Group
UBS Group
Switzerland
+$4.17K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$10.4K
Name Holding Trade Value Shares
Change
Change in
Stake
CD
1
Chapin Davis
Maryland
$17.5K
Two Sigma Investments
2
Two Sigma Investments
New York
$16.9K -$10.4K -25 -28%
Renaissance Technologies
3
Renaissance Technologies
New York
$16K +$24.6K +59 New
UBS Group
4
UBS Group
Switzerland
$7.15K +$4.17K +10 +59%

LICN Hedge Fund Activity: Q2 2023 in Review

4 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Lichen China (LICN) for Q2 2023, worth a combined $57.5K — down 21% from $72.7K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new LICN positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $24.6K. The largest seller was Two Sigma Investments, cutting an estimated $10.4K.

  • 4 institutional investors held Lichen China (LICN) as of Q2 2023, up from 3 in Q1 2023.
  • Funds reported $57.5K of Lichen China stock for Q2 2023, down 21% quarter-over-quarter.
  • 1 fund opened new Lichen China positions in Q2 2023 and 0 closed out, a net change of +1 holder.
  • The largest Lichen China buyer in Q2 2023 was Renaissance Technologies, an estimated $24.6K added.
  • The largest Lichen China seller in Q2 2023 was Two Sigma Investments, an estimated $10.4K sold.

Based on aggregated 13F filings for Q2 2023.